Journal of Clinical Pediatrics ›› 2022, Vol. 40 ›› Issue (1): 63-.doi: 10.12372/jcp.2022.21e0390

Previous Articles     Next Articles

Bernard-Soulier syndrome caused by compound heterozygous variations of GP1BA gene: a case report

WANG Yan, SHEN Diying, ZHANG Jingying, YU Jindan   

  1. The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou 310000, Zhejiang, China
  • Online:2022-01-15 Published:2022-01-11

Abstract: Objective To analyze the clinical characteristics and genetic etiology of a case of Bernard-Soulier syndrome. Methods The clinical and molecular genetic data of a child diagnosed with BSS were reviewed. Results The patient was a 5 -year-old boy. Thrombocytopenia occurred in the newborn period, and the platelet count was maintained at ( 25 ~ 40 ) × 109 /L. Gamma globulin and hormone therapy were not effective. The expression level of platelet membrane glycoproteinⅠbα(GPⅠbα) was 42.4%, which was significantly lower than normal level. Whole exome sequencing detected two variations in the GP 1 BA gene of the child, c. 987 G>A and c. 523 _ 525 delAAC. The Sanger family verified that the variations were derived from their parents respectively and constituted a compound heterozygous variant. Conclusion The variation site of c.523 _ 525 delAAC has not been reported, which expands the BSS gene variation spectrum.

Key words: thrombocytopenia; Bernard-Soulier syndrome; next-generation sequencing, GP 1 BA gene